EVEN AS THE LAST ISSUE of THE DARK REPORT was reaching clients with news of Genzyme Corp.’s offer to buy IMPATH Inc., another big oncology deal was announced. On March 22, 2004, Welsh, Carson, Anderson & Stowe announced an offer of $15.05 per share to purchase all remaining shares of U.S. Oncology, Inc. which it […]
- "Pathology & Oncology Update"
Welsh Carson Pays $1.14 Billion To Acquire U.S. Oncology, Inc.
It’s another billion-dollar Wall Street bet on the future prospects in oncology services
- By Robert Michel
- > From the Volume XI No. 5 - April 5, 2004 Issue
